Level of CSF CXCL10 is highly elevated and decreased after steroid therapy in patients with autoimmune glial fibrillary acidic protein astrocytopathy

ConclusionCSF CXCL10 levels were particularly high in GFAP-A, and changes in levels after treatment correlated with clinical improvements, suggesting CXCL10 involvement in GFAP-A pathogenesis.

Source: Clinical and Experimental Neuroimmunology - October 26, 2022 Category: Neurology Authors: Takayuki Kikuchi, Naoki Takao, Tomoo Sato, Isahaya Kenji, Sakae Hino, Kaburagi Mayumi, Tachikawa Keiji, Ko Riyoko, Soichiro Shibata, Kei Kaburagi, Naoki Iijima, Heisuke Mizukami, Kenzo Sakurai, Junji Yamauchi, Akio Kimura, Takayoshi Shimoha Tags: ORIGINAL ARTICLE Source Type: research